Accepted Manuscript Impact of dietary intake, lifestyle and biochemical factors on metabolic health in obese adolescents I. Aldhoon-Hainerová, V. Hainer, H. Zamrazilová PII:
S0939-4753(17)30096-0
DOI:
10.1016/j.numecd.2017.05.002
Reference:
NUMECD 1722
To appear in:
Nutrition, Metabolism and Cardiovascular Diseases
Received Date: 4 January 2017 Revised Date:
9 April 2017
Accepted Date: 8 May 2017
Please cite this article as: Aldhoon-Hainerová I, Hainer V, Zamrazilová H, Impact of dietary intake, lifestyle and biochemical factors on metabolic health in obese adolescents, Nutrition, Metabolism and Cardiovascular Diseases (2017), doi: 10.1016/j.numecd.2017.05.002. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Impact of dietary intake, lifestyle and biochemical factors on metabolic health in Czech normal weight and obese adolescents
Aldhoon-Hainerová Ia,b, Hainer Va, Zamrazilová Ha Institute of Endocrinology, Prague, Czech Republic
b
RI PT
a
Department of Pediatrics, Third Faculty of Medicine, Charles University, Prague, Czech
SC
Republic
Irena Aldhoon-Hainerová, MD, PhD
M AN U
Corresponding author:
Obesity Management Center, Institute of Endocrinology Národní 8, 116 94 Prague 1, Czech Republic
Phone: +420 723 519 898, Fax: +420 224 905 325
TE D
E-mail:
[email protected]
Word counts: abstract: 245, text: 3 315, number of references: 46, figures: 0, tables: 2
EP
Keywords: Adolescents; Determinants of metabolic health; Lifestyle factors; Metabolically healthy obesity; Metabolic syndrome
AC C
List of abbreviations: MHNW, metabolically healthy normal weight; MUO1, metabolically unhealthy obesity with only one cardiometabolic parameter; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; COPAT, Childhood Obesity Prevalence And Treatment; EI, Eating Inventory; GGT, gamma-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; MHO, metabolically healthy obesity; MUO, metabolically unhealthy obesity; WHtR, waist-to-height ratio 1
ACCEPTED MANUSCRIPT Abstract
2
Background and Aims: Some obese individuals lack metabolic abnormalities. This
3
phenomenon is - denoted Obesity devoid of metabolic abnormalities is known as
4
metabolically healthy obesity (MHO). Limited data on determinants of MHO at adolescence
5
are available. The aim of the study was to examine possible determinants of MHO at
6
adolescence.
7
Methods and Results: From 710 obese adolescents 43 girls and 57 boys were classified as
8
Mmetabolically unhealthy obesity was characterized by the presence of (abdominal obesity
9
and >2 risk components of metabolic syndrome). MHO (absence of any cardiometabolic risk
10
factor) was found in 211 girls and 131 boys (regardless waist circumference) and in 33 girls
11
and 27 boys (without abdominal obesity). In 710 obese adolescents studied according to their
12
metabolic health status and in 441 metabolically healthy normal weight adolescents,
13
lLaboratory and anthropometric parameters, 3-day dietary records, scores of the Eating
14
Inventory and various lifestyle factors were compared evaluated between MHO vs. those
15
unhealthy MHO was defined as being free of any essential component defining metabolic
16
syndrome. The prevalence of MHO regardless waist circumference was higher in girls than in
17
boys (53.1 vs. 41.9%, p<0.001) but comparable when abdominal obesity was excluded (8.3
18
vs. 8.6%). Most of the aAnthropometric variables,were related to metabolic health. The levels
19
of gamma-glutamyl transferase, total and low-density lipoprotein cholesterol in both genders,
20
hs-C-reactive protein in girls and alanine aminotransferase in boys differentiated the two
21
metabolic phenotypes in obese individuals. Uric acid was related to metabolic health only in
22
the analysis of MHO without abdominal obesity. Total hours of sleep, bedtime, and the time
23
of the last daily meal, regular meal consumption and protein intake only in obese boys and
24
screen time, the score of disinhibition and diet composition only in obese girls were found to
AC C
EP
TE D
M AN U
SC
RI PT
1
2
ACCEPTED MANUSCRIPT impact cardiometabolic health status. Scores of the Eating Inventory were not associated with
2
metabolic health.
3
Conclusions: In obese adolescents metabolic health was related to anthropometric and
4
biochemical parameters and only weak associations were found with most of the studied
5
lifestyle factors. Uric acid concentration associated with metabolic health when abdominal
6
obesity was excluded.
RI PT
1
7
SC
8 9
M AN U
10 11 12 13
17 18 19 20 21
EP
16
AC C
15
TE D
14
22 23 24 25 3
ACCEPTED MANUSCRIPT Introduction
2
Obesity is associated with higher prevalence of cardiovascular and metabolic
3
diseasesmorbidity and total and cardiovascular mortality [1]. There are, however, individuals
4
that despite being obese present with favorable metabolic profile [2,3]. This phenomenon is
5
known as metabolically healthy obesity (MHO) and its definition is based either on the
6
absence of cardiometabolic disturbances or on preservation of insulin sensitivity [4-6].
7
Several studies, mainly carried out in adults, have tried to identify determinants and predictors
8
of MHO, including dietary and lifestyle factors [3,7–9]. The role of diet in MHO has been
9
widely studied but been yielded rather inconsistent results. Comparable macronutrient intakes
10
have been reported in individuals with MHO and metabolically unhealthy obesity (MUO) [8-
11
11]. Similarly, inconsistent data were observed when physical activity level in MHO was
12
studied [8]. On the other hand, metabolic health was positively associated with
13
cardiorespiratory fitness [12]. Among children only limited data regarding the role of
14
behavioral and lifestyle factors in determining MHO status exist. A dietary fat intake and
15
moderate physical activity has been identified as independent predictors of health status in
16
children and adolescence [13]. A better compliance to dietary guidelines has been found in
17
MHO adolescents and women in comparison to their MUO counterparts [14]. In a study of
18
Camhi et al. physical activity differed between MHO and MUO in adults but not in
19
adolescents and no effect of screen time was identified [15]. Physical activity was associated
20
with MHO only when defined by insulin resistance [8]. We hypothesized that lifestyle factors
21
may influence metabolic health status already at adolescence. A treatment of obesity in
22
adolescents has so far been mainly focused on promoting a healthy lifestyle. However, it is
23
still questionable whether already in adolescence there are specific determinants of metabolic
24
health related to lifestyle factors. In our previous study we identified subjects that shared the
25
same body weight, height, body mass index (BMI) and waist circumference but differed in
AC C
EP
TE D
M AN U
SC
RI PT
1
4
ACCEPTED MANUSCRIPT cardiometabolic profile [16] we thus speculate that some specific lifestyle behaviors may play
2
a role in metabolic health. An identification of particular factors associated with metabolic
3
health profile could thus be emphasized in the treatment of adolescent obese patients. The aim
4
of our study wasis to reveal potential determinants of MHO particularly with respect to
5
dietary and lifestyle behaviors.
6
RI PT
1
Methods
8
Study population and determination of metabolic health status
9
Czech individualsSubjects of Caucasian origin aged 13.0–17.9 years were recruited between
SC
7
April 2009 and December 2010 within the Childhood Obesity Prevalence And Treatment
11
(COPAT) project. This project was conducted in different regions across the Czech Republic
12
and included a representative cohort established by the stratified random selection and
13
overweight/obese adolescents that had undergone a 4-week weight management program in
14
specialized clinical settings.enrolled adolescents across the whole country from general
15
pediatricians (representative cohort) and from in-patient or outpatient clinics specialized in
16
childhood obesity (obese cohort). We studied created two cohorts based on body mass index
17
(BMI): a group Out of 710 obese participants (397 girls, 313 boys) fulfilling the criteria of
18
obesity defined as by BMI > 97.0 percentile [17] and age 13.0-17.9 years and a group of 441
19
metabolically healthy normal weight individuals (MHNW) with BMI 25.0–75.0 percentile.
20
The total cohort of 710 Czech obese adolescents (397 girls, 313 boys) was studied in relation
21
according to their metabolic health status and gender. Metabolic health was classified
22
according to the number of present cardiometabolic parameters excluding waist
23
circumference. 43 girls and 57 boys were classified as MUO. MUO was defined as the
24
presence of abdominal obesity (waist circumference 10-16 years: ≥ 90.0 percentile or adult
25
cut-off if lower; >16 years: ≥ 94 cm for boys and ≥ 80 cm for girls) and of at least two
AC C
EP
TE D
M AN U
10
5
ACCEPTED MANUSCRIPT essential components of the metabolic syndrome [fasting blood glucose > 5.6 mmol/l;
2
triglycerides > 1.7 mmol/l; high-density lipoprotein cholesterol (HDL-C) for individuals aged
3
13.0–15.9 years: < 1.03 mmol/l and for individuals aged > 16.0 years: girls < 1.29 mmol/l,
4
boys < 1.03 mmol/l; increased systolic or/and diastolic blood pressure] as defined by the
5
International Diabetes Federation definition. The Fourth Report on Blood Pressure with age
6
and gender specific thresholds of blood pressure was used to define increased systolic or/and
7
diastolic blood pressure hypertension [18]. Out of 710 adolescents 211 girls and 131 boys had
8
The MHO that was characterized by the absence of any above mentioned cardiometabolic
9
abnormality regardless of the waist circumference. In order to create MHO cohort
SC
RI PT
1
corresponding to a more strict definition, subjects with abdominal obesity were excluded from
11
the initial MHO cohort (leading to a cohort of 33 girls and 27 boys). Obese adolescents with
12
only one cardiometabolic risk factor (denoted as MUO1) are presented only for statistical
13
analyses but are not discussed within the clinical implication.
14
The study protocol was approved by the Ethicsal Committee of the Institute of Endocrinology
15
in Prague and was in accordance with the Helsinki declaration II. All participants and their
16
parent(s) signed an informed consent.
17
Anthropometric and clinical data
18
In participants in underwear and without shoes body height, weight, and waist, hip and arm
19
circumferences and their z-scores, sum of four skinfolds (biceps, triceps, subscapular and
20
suprailiac skinfolds), trunk and total body fat by bioimpedance (Tanita BC-418 MA, Tanita
21
Corporation, Tokyo, Japan) were assessed by trained staff using standard protocol. We
22
calculated these indexes: BMI and its z-score were assessed according to age- and sex-
23
matched Czech reference population [17]; waist-to-height ratio (WHtR) and body adiposity
24
index (hip circumference divided by body height1.5 minus 18 [19]). In order to evaluate waist
25
circumference z-score we used reference data of the German adolescent population [20]. Two
AC C
EP
TE D
M AN U
10
6
ACCEPTED MANUSCRIPT blood pressure measurements assessed by Omron i-C10 (Omron Healthcare Co., Ltd., Kyoto,
2
Japan) were averaged and used for its evaluation.
3
Lifestyle and dietary data
4
Data on personal history (birth weight and length, duration of breastfeeding - never, < 6
5
months, > 6 months) and family history (occurrence of diabetes, hypertension, heart disease,
6
dyslipidemia disorder, asthma, allergy, cancer in parents and grandparents) were derived from
7
questionnaires. All studied individuals completed the Eating Inventory (EI) questionnaire.
8
The EI assesses three dimensions of human eating attitudes: cognitive restraint, disinhibition
9
and hunger [21,22]. Information on total hours of sleep, bedtime and snoring (“yes” answer if
10
one snores at least sometimes), daily screen time (including television viewing and computer
11
use, based on the total number of hours during one week a daily screen time was calculated),
12
skipping breakfast (“yes” answer if one does not consume breakfast regularly), regular pattern
13
of meal intake (“yes” answer if most of the time one consumes breakfast, lunch and dinner
14
regularly), presence of the night eating (“yes” answer if one wakes up and eats sometimes at
15
night) and time of the last daily meal were collected. The answers “don´t know” were not
16
included in the analyses. Each participant with the assistance of a family member filled out a
17
dietary record for 3 days (two weekdays and one weekend day). From these self-reported
18
records after adjustment for BMI z-score daily intake of energy (megajoules per day),
19
macronutrients - carbohydrate, fat and protein (grams per day and a percentage of total energy
20
intake), fiber (grams per day) and calcium (milligrams per day) were calculated using
21
NutriMaster SE Version 1 (Abbott Park, Illinois, USA).
22
Laboratory investigations
23
All biochemical samples [blood glucose, lipid profile, liver function tests, C-reactive protein
24
(CRP),
25
spectrophotometrically (kits and on Cobas 6000 analyzer,; both Roche diagnostics,
AC C
EP
TE D
M AN U
SC
RI PT
1
uric
acid]
were
collected
after
7
an
overnight
fast
and
determined
ACCEPTED MANUSCRIPT Mannheim, Germany). Blood glucose was measured spectrophotometrically using an
2
enzymatic reference method with hexokinase. A high sensitivity C-reactive protein (hs-CRP)
3
was measured spectrophotometrically using an immunoturbidimetric assay. Triglycerides,
4
total cholesterol, HDL-C, low-density lipoprotein cholesterol (LDL-C), uric acid, gamma-
5
glutamyl transferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase
6
(ALT) were measured spectrophotometrically using an enzymatic method.
7
Statistical analyses
8
Due to a non-normal distribution data were analyzed by non-parametric Mann–Whitney test
9
for differences between two independent groups (Table 1). To eliminate skewed data
SC
RI PT
1
distribution and heteroscedasticity, the original data from dietary records were transformed by
11
power transformation to attain a constant variance and symmetric distribution of data and
12
residuals, and data underwent general linear model ANOVA analysis (Table 2). Data are
13
presented as medians with 95 % confidence intervals. In the case of categorical data, Chi-
14
squared test was applied and data are presented as percentages (Table 2). The statistical
15
software NCSS 2004 (Kaysville, Utah, 190 USA) and Statgraphics Centurion, version XV
16
from Statpoint Inc. (Herndon, Virginia, USA) were used.
17
EP
TE D
M AN U
10
Results
19
MHO regardless waist circumference
20
The prevalence of MHO was significantly higher in girls than in boys (53.1 vs. 41.9 %, p <
21
0.001). In both genders the MHO group was significantly younger, had lower sum of four
22
skinfolds, WHtR, percentage of total fat and lower z-scores of BMI and of waist
23
circumference compared to those with MUO (Table 1). In contrast to girls, the percentage of
24
total and trunk (25.7 % vs. 26.7 %) body fat (girls: 32.1 vs 34.7 %, p= 0.004; boys: 26.5 vs.
25
27.8 %, p = 0.081) and as well as the body adiposity index did not differ between MHO and
AC C
18
8
ACCEPTED MANUSCRIPT MUO boys (Table 1). As expected all anthropometric parameters significantly differed
2
between the normal weight group and all categories of obese subjects in both genders. The
3
levels of gamma-glutamyl transferase (GGT), total and LDL-Clow-density lipoprotein
4
cholesterol in both genders, hs-CRP in girls and alanine aminotransferase (ALT) in boys
5
distinguished the two metabolic phenotypes in obese individuals. Our results further showed
6
that boys with MUOMHO had significantly higherlower protein intake and girls with
7
MUOMHO had significantly lowerhigher intakes of total energy, carbohydrate, and fat and
8
calcium in grams than those with MUOMHO (Table 2). A screen time in obese girls and In
9
obese boys a total hours of sleep, the bedtime and the time of last daily meal in obese boys
10
were found to impact cardiometabolic health status (Table 2). A tendency to regular meal
11
consumption in those with MHO was found in boys. Other factors (e.g. night eating, breakfast
12
skipping) did not seem to play a role in metabolic health (Table 2).
13
MHO without abdominal obesity
14
The prevalence of MHO without abdominal obesity dropped to 8.3 % in girls and 8.6 % in
15
boys. Apart from the above mentioned biochemical parameters the concentration of uric acid
16
in both gender and ALT in girls and AST concentrations in boys differed between the two
17
metabolic health phenotypes (Table 1). MHO girls presented lower score of disinhibition and
18
lower frequency of snoring when compared to those with metabolically unhealthy abdominal
19
obesity (Table 2). A higher number of total hours of sleep and regular meal consumption in
20
boys were associated with MHO (Table 2). In both genders uric acid and aspartate
21
aminotransferase concentrations were not related to metabolic health status. Laboratory
22
findings of MHNW individuals to those with MHO did reach a significant difference except
23
for blood glucose in both genders and for triglycerides, total cholesterol and aspartate
24
aminotransferase in girls (Table 1).
AC C
EP
TE D
M AN U
SC
RI PT
1
9
ACCEPTED MANUSCRIPT The significant difference was reached for intakes of total energy and carbohydrate between
2
MHNW girls and girls with MHO and also those with one cardiometabolic risk factor (Table
3
2). A significantly lower intake of fiber was found in MHNW than MHO girls. Similarly,
4
MHNW boys presented with significantly higher intake of total energy, fat and carbohydrate
5
than obese boys. Scores of EI were not related to cardiometabolic health in obese participants.
6
However, differences in scores were only found when obese groups were compared to
7
MHNW group. In comparison to normal weight counterparts obese adolescents reported
8
higher restraint and disinhibition scores in both genders and higher hunger score only in boys
9
(Table 2).
SC
RI PT
1
Significant differences were revealed in the prevalence of snoring in both genders. In the case
11
of snoring the significance was, however, only between normal-weight and all obese groups,
12
thus not related to metabolic health status of obese individuals (Table 2).
13
In both MHO definitions neither birth weight and birth length nor duration of breastfeeding
14
did impact metabolic outcomes during adolescence (Table 2). Family history of the
15
participants was not found to be related to metabolic health in both boys and girls (data not
16
shown).
EP
17
TE D
M AN U
10
Discussion
19
This is one of the largest studies related to MHO in pediatric cohort. Of the total of 710 obese
20
adolescents 442 were selected either as having MHO or MUO. Our study focused on A broad
21
variety of lifestyle factors and analyzing their potential impact on cardiometabolic health was
22
studiedin 710 obese adolescentsand 441 normal weight counterparts. Regardless waist
23
circumference Among obese adolescents, 41.9 % boys and 53.1 % girls were free of any
24
cardiometabolic disturbances characterizing the metabolic syndrome except for increased
25
waist circumference. The higher prevalence of MHO in females is widely recognized and is in
AC C
18
10
ACCEPTED MANUSCRIPT accordance with previous findings [4,8] including those carried out at adolescence [7,15].
2
Several studies by Camhi et al. reported 65 to 68 % prevalence of MHO among obese U.S.
3
adolescents based on none or one abnormal cardiometabolic risk factor [8,13]. Girls and boys
4
with MHO were significantly younger and had, as expected, more favorable anthropometric
5
profile than those with MUO as found in other studies [7,9]. Several studies pointed out that
6
MHO children are more likely to be younger and in earlier stage of puberty [3]. It is thus
7
questionable whether those identified as MHO in younger age were too young to develop
8
features of metabolic syndrome or they were real carriers of MHO phenotype. An interesting
9
study of Li et al. looked at the stability of MHO in children with an average follow-up of 24
10
years [23]. The adult cardiometabolic profile in subjects identified as MHO in childhood was
11
more favorable than that of metabolically unhealthy normal weight individuals and
12
comparable to healthy normal weight children. It is thus still to be determined what factors are
13
important to achieve and maintain a good metabolic health throughout the life course.
14
Apparently visceral fat accumulation represented by waist circumference plays an important
15
role in adverse metabolic outcomes already at adolescence. In our cohort both the waist
16
circumference and the percentage of total and trunk body fat mass measured by bioimpedance
17
was different between the two metabolic phenotype groups of girls but not ofand boys. On the
18
other hand, the waist circumference of both boys and girls with MUO was significantly higher
19
than in their metabolically healthy counterparts. We are aware of the fact that abdominal
20
obesity compared to general obesity is associated with greater cardiovascular risks [24] and is
21
a mandatory diagnostic criterion for definition of metabolic syndrome [25]. Lately it has been
22
stressed that prevention strategies should be focused on abdominal obesity also in children
23
and adolescents [26]. Based on these facts we established a second cohort of MHO in which
24
individuals besides being free of any cardiometabolic abnormality also presented with normal
AC C
EP
TE D
M AN U
SC
RI PT
1
11
ACCEPTED MANUSCRIPT waist circumference. The prevalence of MHO then dropped to around 8.0 % in both genders
2
which points out to the fact that most of our obese adolescents display abdominal obesity.
3
Regardless the definition of MHO Our data showed that the level of GGT in both genders was
4
related to metabolic health. A higher level of GGT has been associated with higher
5
cardiometabolic risk clustering and exhibited an ability to distinguish between the two
6
phenotypes in adolescents [7,27] as well as to a predictor of homeostasis model assessment of
7
insulin resistance index in our previously published study [28].
8
D´Adamo demonstrated that fatty liver, independent of visceral fat, plays a central role in the
9
state of insulin resistance in obese adolescents [29]. It is therefore now recognized that non-
10
alcoholic fatty liver disease share the pathophysiologic basis of insulin resistance as found in
11
the development of metabolic syndrome and is considered as hepatic manifestation of
12
metabolic syndrome [30]. Additionally, tThe levels of hs-CRP in girls and ALT in boys were
13
different between MHO and MUO groups in the analysis of MHO regardless waist
14
circumference. This is in agreement with In a recent paper in which the level of ALT was
15
only in boys associated with higher cardiometabolic risk score also only in boys [27].
16
Except for the level of uric acid and aspartate aminotransferase most of the studied
17
biochemical parameters were related to metabolically healthy phenotype in both genders. On
18
contrary, uUric acid has recently been identified as the best predictor of MUO [7]. This is in
19
agreement with the study of Avula and Shenoy, who demonstrated that hyperuricemia, even
20
after adjusting for potential confounders, was strongly and independently associated with
21
insulin resistance [31]. A significant difference in the level of uric acid was only found in the
22
analysis between MUO and MHO without abdominal obesity.
23
Shorter sleep duration associated with higher CRP [16]. Some authors even speculated
24
whether the negative effect of short sleep duration on the development of cardiometabolic
AC C
EP
TE D
M AN U
SC
RI PT
1
12
ACCEPTED MANUSCRIPT diseases was mediated by CRP [16]. Our results did not confirm this hypothesis either in boys
2
or in girls.
3
A study by Appannah et al. showed that already at adolescence energy dense, high fat, low
4
fiber dietary pattern was positively associated with cardiometabolic risk factors [32]. In our
5
study the proportion of nutrients in the diet of obese boys, apart from the intake of protein,
6
was comparable between the metabolically healthy and unhealthy individuals. Diet
7
composition of obese boys was similar between metabolically healthy and unhealthy
8
individuals. This is in line with reports in adults [8,9]. Intakes of total energy, carbohydrate,
9
and fat and calcium were paradoxically lower in obese girls with unhealthy phenotype in
SC
RI PT
1
comparison to both the MHO and MHNW girls. With respect to our finding of higher intake
11
of calcium in MHO, a study of Camhi showed that adolescents with MHO consumed a higher
12
quantity of milk than their MUO counterparts [14]. According to Zemel dietary calcium and
13
dairy foods have demonstrated an antiobesity effect in experimental and population studies, as
14
well as in randomized clinical trials. In addition, dietary calcium may suppress oxidative and
15
inflammatory stress which is related to cardiometabolic risks in obesity [33]. Hur et al. in
16
their recent paper did not find any significant associations between total sugar intake and both
17
adiposity and continuous metabolic syndrome scores in children and adolescents [34].
18
Another paradoxical finding was in agreement with a study by Manu et al. in which MHO
19
females presented with lower intake of dietary fiber [10]. We may only speculate about these
20
controversial findings. An inaccuracy of self-reported dietary records and possible interaction
21
of nutrients with genes may partly explain these trends.
22
In adults, restraint and hunger scores of factors of the EI were significant predictors of the
23
diseases characterizing metabolic syndrome [35]. Moreover, in a quota sample of Czech
24
adults comprised of 1429 men and 1624 women, disinhibition was positively and restraint
25
negatively associated with BMI and waist circumference. In our studied cohort of obese
AC C
EP
TE D
M AN U
10
13
ACCEPTED MANUSCRIPT adolescents, we did not find any relationships between scores of the EI and metabolic
2
health. However, significantly lower disinhibition score in girls with MHO without abdominal
3
obesity compared to those with metabolically unhealthy abdominal obesity supports our
4
previous finding of a positive association between the dietary disinhibition and abdominal
5
obesity observed in adults [35]. In both genders, restraint and disinhibition scores in normal
6
weight subjects were significantly lower when compared to scores of all three obese groups.
7
This was also true for hunger score, however, only in boys.
8
At adolescence screen time was found to be associated with BMI but results concerning an
9
association with and cardiovascular risks have been controversial [9,15,36,37]. In line with
SC
RI PT
1
our finding also previously published sStudies in adolescents and adults however did not find
11
any association of screen time or sedentary behaviors with metabolically healthy phenotype
12
[9,15]. Even though our MHO girls paradoxically showed higher screen time than their MUO
13
counterparts, the real time difference is negligible. It could be speculated that girls with MUO
14
may be aware of their health status and thus be under pressure to implement healthier
15
lifestyle.
16
Shorter sleep duration has not only been related to increased body weight [38] but in some
17
studies also to cardiovascular risks even in children [39]. In both MHO definitions used we
18
found an association of shorter sleep duration with adverse cardiometabolic outcomes only in
19
boys. Lee et al. did not find any association of sleep duration with metabolic syndrome except
20
for an association of short sleep with elevated blood pressure [23]. An adult study showed that
21
women but not men with MHO slept longer than those at metabolic risk [8] although obesity
22
risk was higher in sleep-deprived men than in sleep-deprived women [40]. A recent study in
23
adolescents and adults has concluded snoring, but not sleep duration, as an
24
independent risk factor for dyslipidemia and metabolic syndrome [25]. The prevalence of
25
snoring significantly differed between all four studied groups but was not related to metabolic
AC C
EP
TE D
M AN U
10
14
ACCEPTED MANUSCRIPT health but to obesity itself. Recently, an inverse relationship between the sleep duration and
2
metabolic syndrome was revealed only in subjects under 50 years of age [41].
3
A role of skipping breakfast in obesity and cardiovascular risks has also been documented in
4
adults and children [42]. According to our results neither skipping breakfast nor eating at
5
neither night nor regular meal consumption seemed to play a role in metabolic health. Even
6
though the time of last daily meal and bedtime was associated with cardiometabolic health
7
status in boys, the time difference less than half an hour has probably little clinical relevance.
8
Regular meal consumption in boys was more frequently found in those healthy ones. In an
9
adult study an irregular intake of energy appeared to have an increased cardio-metabolic risk
SC
RI PT
1
[43].
11
An association of birth weight with metabolic health incl. type 2 diabetes has been
12
demonstrated published [44]. Birth weight and length did not relate to metabolic outcomes at
13
adolescence in our study. As others we have recently showed that more than birth weight
14
itself a weight trajectory during early childhood may impact health later in life [16]. However,
15
Tthere are inconsistent results with respect to the duration of breastfeeding and its impact on
16
cardiometabolic health outcomes [36,45].
17
Family history of the participants related to cardiovascular and metabolic diseases was not
18
associated with metabolic health either in boys or in girls as found by others [46]. We have to
19
take into account that certain hereditary traits are manifested later in life.
20
There are several limitations of the present study. In order to assess various lifestyle factors
21
we used self-reported questionnaires instead of more precise tools. This is due to the initial
22
design of our COPAT project in which more than 2,000 participants were recruited and thus
23
questionnaires were more accessible. We assume as the level of bias reporting and inaccuracy
24
was similar within the obese participants. We were unable to analyze physical activity in our
25
studied cohort which is also an important aspect for metabolic health. The study was solely
AC C
EP
TE D
M AN U
10
15
ACCEPTED MANUSCRIPT performed in Czech Caucasian population and thus we were unable to compare our results to
2
other populations or ethnic groups. At last, body composition in the present study was
3
assessed by bioimpedance and not by more precise imaging techniques. Despite these
4
limitations we were able to examine various determinants of metabolic phenotypes in one of
5
the largest cohort of obese adolescents.
6
In conclusion, the current study demonstrated that MHO regardless waist circumference iswas
7
more common in adolescent girls than boys but comparable when abdominal obesity was
8
excluded. Most of the aAnthropometric variables and the levels of GGT, total and low-density
9
lipoprotein cholesterol in both genders were related to metabolic health. Additional Some of
SC
RI PT
1
the biochemical parameters were found to be gender specific with respect to the ability to
11
distinguish metabolic health status (CRP in girls and ALT in boys). Uric acid was related to
12
metabolic health only in the analysis of MHO without abdominal obesity. Among lifestyle
13
factors tTotal hours of sleep, bedtime, and the time of the last daily meal and protein intake
14
only in obese boys and screen time and dietary intake only in girls weresignificantly differed
15
between MHO and MUO.found to influence cardiometabolic health. Eating behavior
16
evaluated by the EI was not associated with cardiometabolic health status among adolescents.
17
The score of dietary disinhibition and fat intake in girls and total hours of sleep and regular
18
meal consumption in boys were related to the metabolic health only if the MHO without
19
abdominal obesity was evaluated.
TE D
EP
AC C
20
M AN U
10
21
Acknowledgements
22
This study was supported by Ministry of Health of the Czech Republic - DRO (Institute of
23
Endocrinology - EÚ, 00023761) and by PRVOUK P31 as they had contributed funding for
24
the project from which data were derived for the present study. We would like to thank the
16
ACCEPTED MANUSCRIPT 1
study participants and their families, pediatricians and weight management centers, Lenka
2
Dušátková and Barbora Sedláčková for laboratory analyses and data storage.
3 References
5
1. Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and
RI PT
4
6
adolescence on morbidity and premature mortality in adulthood: systematic review. Int J
7
Obes (Lond) 2011;35:891-8.
2. Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of
9
metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008;34:183–4.
11 12
3. Phillips CM. Metabolically healthy obesity across the life course: epidemiology,
M AN U
10
SC
8
determinants, and implications. Ann N Y Acad Sci. 2016. doi: 10.1111/nyas.13230. 4. Rey-López JP, de Rezende LF, Pastor-Valero M Tess BH. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the
14
definitions used. Obes Rev 2014;15:781–90.
15 16
TE D
13
5. Plourde G, Karelis AD. Current issues in the identification and treatment of metabolically healthy but obese individuals. Nutr Metab Cardiovasc Dis 2014;24:455–9. 6. Aldhoon-Hainerová I, Zamrazilová H, Hill M, Hainer V. Insulin sensitivity and its
18
relation to hormones in adolescent boys and girls. Metabolism 2017;67:90-98.
EP
17
7. Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT et al. Uric acid
20
best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth
21
and adults. Obesity (Silver Spring) 2013;21:E71–7.
22
AC C
19
8. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP et al.
23
Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS
24
One 2013;8:e76188.
17
ACCEPTED MANUSCRIPT 1
9. Hankinson AL, Daviglus ML, Van Horn L, Chan Q, Brown I, Holmes E et al. Diet
2
composition and activity level of at risk and metabolically healthy obese American adults.
3
Obesity (Silver Spring) 2013;21:637–43.
4
10. Manu P, Ionescu-Tirgoviste C, Tsang J, Napolitano BA, Lesser ML, Correll CU. Dysmetabolic signals in "Metabolically Healthy" Obesity. Obes Res Clin Pract
6
2012;6:e9–e20.
7
RI PT
5
11. Kimokoti RW, Judd SE, Shikany JM, Newby PK. Metabolically Healthy Obesity Is Not Associated with Food Intake in White or Black Men. J Nutr 2015;145:2551-61.
9
12. Ortega FB, Lee D, Katzmarzyk PT, Ruiz JR, Sui X, Church TS et al. The intriguing
SC
8
metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness.
11
Eur Heart J 2013;34: 389–97.
13 14
13. Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD. Predictors of metabolically healthy obesity in children. Diabetes Care 2014;37:1462-8.
14. Camhi SM, Whitney Evans E, Hayman LL, Lichtenstein AH, Must A. Healthy eating
TE D
12
M AN U
10
15
index and metabolically healthy obesity in U.S. adolescents and adults. Prev
16
Med 2015;77:23-7.
15. Camhi SM, Waring ME, Sisson SB, Hayman LL, Must A Physical activity and screen
EP
17
time in metabolically healthy obese phenotypes in adolescents and adults. J
19
Obes 2013;984613.
AC C
18
20
16. Zamrazilova H, Weiss R, Hainer V, Aldhoon-Hainerová I. Cardiometabolic Health in
21
Obese Adolescents Is Related to Length of Obesity Exposure: A Pilot Study. J Clin
22
Endocrinol Metab 2016;101:3088–395.
23
17. Kobzova J, Vignerova J, Blaha P, Krejcovský L, Riedlová J. The 6th nationwide
24
anthropological survey of children and adolescents in the Czech Republic in 2001. Cent
25
Eur J Public Health 2004;12:126–30. 18
ACCEPTED MANUSCRIPT 1
18. National High Blood Pressure Education Program Working Group on High Blood
2
Pressure in Children and Adolescent. The fourth report on the diagnosis, Evaluation and
3
treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76. 19. Dias IB, Panazzolo DG, Marques MF, Paredes BD, Souza MG, Manhanini DP et
5
al.Relationships between emerging cardiovascular risk factors, z-BMI, waist
6
circumference and body adiposity index (BAI) on adolescents. Clin Endocrinol
7
(Oxf) 2013;79:667-74.
10 11
adolescents. World J Pediatr 2011; 7:16–23.
SC
9
20. Haas GM, Liepold E, Schwandt P. Percentile curves for fat patterning in German
21. Stunkard AJ, Messick S. The Three-Factor Eating Questionnaire to measure dietary
M AN U
8
RI PT
4
restraint, disinhibition and hunger. J Psychosom Res 1985;29:71–83. 22. Gallant AR, Tremblay A, Pérusse L, Bouchard C, Després JP, Drapeau V.The Three-
13
Factor Eating Questionnaire and BMI in adolescents: results from the Québec family
14
study. Br J Nutr 2010;104:1074-9.
15
TE D
12
23. Li S, Chen W, Srinivasan SR, Xu J, Berenson GS. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart
17
Study. Am J Epidemiol 2012;176:S142-9.
19 20 21 22 23
24. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
AC C
18
EP
16
25. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S et al. The metabolic syndrome in children and adolescents. Lancet 2007;369:2059-61. 26. Plourde G. Is there a definition of metabolically health obese pediatric patients? Endocrinol Diabetes Metab J 2017;S1(110): 1-3.
19
ACCEPTED MANUSCRIPT 1
27. Labayen I, Ruiz JR, Ortega FB, Davis CL, Rodríguez G, González-Gross M et al. Liver
2
enzymes and clustering cardiometabolic risk factors in European adolescents: the
3
HELENA study. Pediatr Obes 2015;10:361–370.
4
28. Aldhoon-Hainerová I, Zamrazilová H, Dušátková L, Sedláčková B, Hlavatý P, Hill M et al. Glucose homeostasis and insulin resistance: prevalence, gender differences and
6
predictors in adolescents. Diabetol Metab Syndr 2014;6:100.
RI PT
5
29. D´Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, Northrup V et al. Central role of
8
fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care
9
2010; 33:1817–22.
11 12 13
30. Tarantino G, Finelli C. What about non-alcoholic fatty liver disease as a new criterion to
M AN U
10
SC
7
define metabolic syndrome? World J Gastroenterol 2013;19:3375-84. 31. Avula NR, Shenoy D. Evaluation of association of hyperuricamia with metabolic syndrome and insulin resistance. J Clin Diagn Res 2016; 10:OC32-OC34. 32. Appannah G, Pot GK, Huang RC, Oddy WH, Beilin LJ, Mori TA et al. Identification of a
15
dietary pattern associated with greater cardiometabolic risk in adolescence. Nutr Metab
16
Cardiovasc Dis 2015;25:643–50.
19
EP
18
33. Zemel MB. Proposed role of calcium and dairy food components in weight management and metabolic health. Phys Sportsmed 2009;37:29-39.
AC C
17
TE D
14
34. Hur YI, Park H, Kang JH, Lee HA, Song HJ, Lee HJ et al. Associations between
20
Sugar Intake from Different Food Sources and Adiposity or Cardio-Metabolic Risk in
21
Childhood and Adolescence: The Korean Child-Adolescent Cohort Study.
22
Nutrients 2015;8(1).
23
35. Hainer V, Kunesova M, Bellisle F, Parizkova J, Braunerova R, Wagenknecht M et al. The
24
Eating Inventory, body adiposity and prevalence of diseases in a quota sample of Czech
25
adults. Int J Obes (Lond) 2006;30:830–86. 20
ACCEPTED MANUSCRIPT 1
36. Brambilla P, Bedogni G, Pietrobelli A, Cianfarani S, Agostoni C. Predictors of blood
2
pressure at 7–13 years: The "new millennium baby" study. Nutr Metab Cardiovasc
3
Dis 2016;26:706–12.
4
37. Martinez-Gomez D, Eisenmann JC, Healy GN, Gomez-Martinez S, Diaz LE, Dunstan DW et al. Sedentary behaviors and emerging cardiometabolic biomarkers in adolescents. J
6
Pediatr 2012;160:104–110.
8 9
38. Lee JA, Park HS. Relation between sleep duration, overweight, and metabolic syndrome in Korean adolescents. Nutr Metab Cardiovasc Dis 2014;24:65–71.
SC
7
RI PT
5
39. Navarro-Solera M, Carrasco-Luna J, Pin-Arboledas G, González-Carrascosa R, Soriano JM, Codoñer-Franch P. Short Sleep Duration Is Related to Emerging Cardiovascular Risk
11
Factors in Obese Children. J Pediatr Gastroenterol Nutr 2015;61:571–56.
M AN U
10
12
40. Patel SR. Reduced sleep as an obesity risk factor. Obes Rev 2009;10 Suppl 2:61-8.
13
41. Kim NH, Shin DH, Kim HT, Jeong SM, Kim SY, Son KY. Associations between Metabolic Syndrome and Inadequate Sleep Duration and Skipping Breakfast. Korean J
15
Fam Med 2015;36:273-7.
TE D
14
42. Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FB et al. Prospective study
17
of breakfast eating and incident coronary heart disease in a cohort of male US health
18
professionals. Circulation 2013;128:337–343. 43. Pot GK, Hardy R, Stephen AM. Irregular consumption of energy intake in meals is
AC C
19
EP
16
20
associated with a higher cardiometabolic risk in adults of a British birth cohort. Int J Obes
21
(Lond) 2014;38:1518-24.
22 23 24 25
44. Zimmermann E, Gamborg M, Sørensen TI, Baker JL. Sex Differences in the Association Between Birth Weight and Adult Type 2 Diabetes. Diabetes 2015;64:4220–5. 45. González-Jiménez E, Montero-Alonso MA, Schmidt-RioValle J, García-García CJ, Padez C. Metabolic syndrome in Spanish adolescents and its association with birth weight, 21
ACCEPTED MANUSCRIPT 1
breastfeeding duration, maternal smoking, and maternal obesity: a cross-sectional study.
2
Eur J Nutr 2015;54:589–97.
3
46. Ajala O, Hosking J, Metcalf BS, Jeffery AN, Voss LD, Wilkin TJ. The contribution of parental BMI to the metabolic health of their offspring: a longitudinal cohort study
5
(EarlyBird 55). Pediatr Obes 2012;7:143–50.
6
8 9
47. Camhi SM1, Katzmarzyk PT. Prevalence of cardiometabolic risk factor clustering and body mass index in adolescents. J Pediatr 2011;159:303–7.
SC
7
RI PT
4
48. Martinez-Gomez D, Eisenmann JC, Gomez-Martinez S, Hill EE, Zapatera B, Veiga OL et al. Sleep duration and emerging cardiometabolic risk markers in adolescents. The
11
AFINOS study. Sleep Med 2011;12:997–1002.
13 14
49. Lee JA, Park HS. Relation between sleep duration, overweight, and metabolic syndrome in Korean adolescents. Nutr Metab Cardiovasc Dis 2014;24:65–71. 50. Brockmann PE, Damiani F, Smith DL, Castet A, Nuñez F, Villarroel L et al. Metabolic
TE D
12
M AN U
10
consequences of snoring in adolescents and younger adults: A population study in Chile.
16
Int J Obes (Lond) 2016;40:1510–4.
18
AC C
17
EP
15
22
ACCEPTED MANUSCRIPT
Table 1: Characteristics of the study cohort Boys
0.008
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
0.012
0.014
EP
AC C
RI PT
0.003
SC
P2
MHO MHO regardless without waist abdominal circumference obesity (n = 131) (n = 27)
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.008
< 0.001
< 0.001 < 0.001 1
MUO (n = 57)
5.0 (4.91, 5.06) 1.29 (1.23, 1.32) 0.89 (0.83, 0.98) 121 (120, 124) 78 (75, 79)
5.0 (4.83, 5.15) 1.29 (1.18, 1.39) 0.87 (0.69, 1.15) 127 (122, 132) 75 (73, 80)
5.25 (5.11, 5.34) 0.91 (0.88, 0.94) 2.18 (1.94, 2.30) 134 (131, 138) 85 (82, 87)
14.7 (14.4, 15.1) 29.5 (28.7, 30.2) 2.48 (2.41, 2.64) 93.5 (92.0, 95.0) 2.20 (2.11, 2.27) 0.54
16.5 (15.3, 17.0) 27.5 (26.8, 27.8) 2.01 (1.94, 2.13) 85.0 (83.0, 88.0) 1.74 (1.55, 2.04) 0.49
15.6 (15.3, 16.0) 33.1 (31.0, 34.4) 3.02 (2.71, 3.15) 103.0 (98.0, 107.0) 2.66 (2.46, 2.88) 0.58
M AN U
P1
TE D
Girls MHO MHO – regardless without MUO waist abdominal (n = 43) circumference obesity (n = 211) (n = 33) Criteria definition 4.81 4.75 4.94 BG (4.75, 4.87) (4.49, 4.91) (4.74, 5.37) mmol/l 1.37 1.46 1.15 HDL-C (1.34, 1.40) (1.33, 1.60) (0.99, 1.22) mmol/l 0.86 0.68 1.83 TG (0.81, 0.92) (0.58, 0.82) (1.74, 2.0) mmol/l 115 115 129 BPs (113, 116) (109, 121) (122, 134) mm Hg 76 74 83 BPd (74, 77) (72, 77) (80, 89) mm Hg Anthropometric and biochemical characteristics 15.0 15.0 16.1 Age (14.7, 15.2) (14.0, 15.7) (14.6, 16.9) (years) 29.2 27.0 32.4 BMI (28.8, 29.7) (26.5, 27.5) (31.4, 33.0) kg/m2 2.45 2.08 2.89 BMI (2.39, 2.60) (1.97, 2.19) (2.74, 3.02) z-score 86.0 77.0 91.0 Waist (85.0, 88.0) (75.0, 77.5) (89.0, 93.5) cm 2.45 2.01 2.78 Waist (2.32, 2.56) (1.77, 2.40) (2.56, 2.98) z-score 0.52 0.47 0.56 WHtR
P1
P2
< 0.001
0.004
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001
0.011
< 0.001 < 0.001
0.003
0.103
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.002
< 0.001
ACCEPTED MANUSCRIPT
(0.52, 0.53) (0.46, 0.48) (0.54, 0.57) (0.53, 0.55) (0.47, 0.51) (0.55, 0.61) 37.1 32.7 39.8 30.8 23.0 33.0 0.011 < 0.001 0.046 < 0.001 (36.2, 38.2) (30.6, 33.9) (38.3, 41.4) (28.4, 32.1) (22.3, 23.9) (29.3, 35.4) 88.0 70.0 101.0 84.0 63.0 91.5 < 0.001 < 0.001 0.008 < 0.001 (86.0, 92.0) (66.0, 76.0) (94.0, 109.0) (78.0, 89.0) (53.5, 71.0) (82.0, 98.0) 33.7 33.3 35.2 29.6 26.8 29.7 0.002 0.001 0.970 0.002 (33.2, 34.1) (31.3, 34.3) (34.0, 36.3) (28.9, 30.7) (25.8, 29.1) (28.5, 30.4) 1.62 0.73 4.01 1.90 0.79 1.37 hs-CRP 0.001 < 0.001 0.481 0.023 (1.32, 2.14) (0.45, 1.48) (2.63, 4.76) (1.24, 2.50) (0.64, 1.54) (1.12, 2.19) mg/l 4.23 4.10 4.95 4.04 3.90 4.50 TC < 0.001 0.001 < 0.001 < 0.001 (4.09, 4.33) (3.96, 4.54) (4.41, 5.20) (3.94, 4.30) (3.34, 4.18) (4.15, 4.93) mmol/l 2.38 2.35 2.84 2.39 2.13 2.76 LDL-C 0.001 0.004 < 0.001 < 0.001 (2.29, 2.50) (2.13, 2.54) (2.50, 3.24) (2.15, 2.49) (1.74, 2.41) (2.45, 3.14) mmol/l 342 320 370 412 374 442 UA 0.271 0.003 0.055 0.001 (332, 354) (281, 334) (331, 384) (383, 427) (301, 412) (413, 464) µmol/l 0.29 0.23 0.31 0.42 0.36 0.57 ALT 0.337 0.003 < 0.001 < 0.001 (0.26, 0.32) (0.22, 0.25) (0.26, 0.36) (0.37, 0.44) (0.28, 0.42) (0.48, 0.75) µkat/l 0.38 0.35 0.37 0.48 0.47 0.52 AST 0.648 0.675 0.160 0.028 (0.36, 0.39) (0.32, 0.40) (0.33, 0.39) (0.46, 0.50) (0.41, 0.49) (0.46, 0.59) µkat/l 0.23 0.18 0.27 0.31 0.26 0.43 GGT 0.008 < 0.001 < 0.001 0.002 (0.21, 0.24) (0.17, 0.21) (0.24, 0.32) (0.29, 0.35) (0.24, 0.38) (0.38, 0.48) µkat/l Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BAI, body adiposity index; BG, blood glucose; BMI, body mass index; BPd, diastolic blood pressure; BPs, systolic blood pressure; hs-CRP, high-sensitivity C-reactive protein; GGT, gamma-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MHO, metabolically healthy obesity; MUO, metabolically unhealthy obesity; n, number of subjects; SSF, sum of four skinfolds; TC, total cholesterol; TG, triglycerides; UA, uric acid; WHtR, waist-to-height ratio Data are presented as medians (95 % confidence intervals). P1 = MHO – regardless waist circumference vs. MUO P2 = MHO – without abdominal obesity vs. MUO
AC C
EP
TE D
M AN U
SC
RI PT
Total fat % SSF (mm) BAI
2
ACCEPTED MANUSCRIPT
Table 2: Lifestyle factors and data on early life related to cardiometabolic health status
0.970
M AN U
0.229
P2
SC
P1
0.116
0.982
0.350
0.311
0.010*
0.076
TE D
Breastfeeding never † (“yes” < 6 months answer; %) ≥ 6 months Energy intake (MJ per day) Carbohydrate (g per day) Protein (g per day) Fat (g per day) Calcium intake (mg per day) Fiber (g per day) EI - Restraint EI - Disinhibition EI - Hunger
50 (49, 50) 3300 (3100, 3450) 43 43 14 6.3 (5.5, 7.3) 198 (158, 221) 63.4 (55.5, 69.7) 56.1 (45.5, 64.4) 588 (461, 739) 9.5 (9.0, 12.0) 8 (6, 9) 4 (3, 5) 3 (2, 5)
EP
(g)
AC C
Birth length (cm) Birth weight
MUO (n = 43)
0.035*
0.203
0.275*
0.950
0.002*
0.006
0.047*
Boys MHO MHO regardless without MUO waist abdominal (n = 57) (n = 131) obesity (n = 27) 51 51 51 (50, 51) (50, 51) (50, 51) 3430 3600 3600 (3310, (3450, (3450, 3550) 3710) 3710) 47 52 56 33 33 35 20 15 9 8.8 10.1 9.2 (7.9, 9.5) (8.3, 11.6) (8.4, 10.5) 265 323 285 (237, 293) (225, 393) (247, 324) 76.0 91.5 79.8 (69.4, 79.6) (77.8, 95.2) (72.5, 96.0) 75.8 83.2 85.5 (72.5, 80.8) (66.3, 102) (73.4, 95.6) 730 833 760 (667, 843) (661, 984) (631, 886) 12.0 12.0 12.0 (11.0, 13.0) (11.0, 14.0) (10.0, 14.0) 6 (5, 7) 4 (2, 7) 6 (4, 7) 4 (3, 5) 4 (2, 5) 3 (3, 5) 4 (4, 5) 3 (2, 5) 4 (3, 5)
RI PT
Girls MHO MHO – regardless without waist abdominal (n = 211) obesity (n = 33) 50 50 (50, 50) (49, 50) 3400 3200 (3300, (3100, 3450) 3400) 34 28 39 47 28 25 7.8 7.6 (7.0, 8.1) (6.7, 8.5) 227 229 (216, 242) (204, 269) 64.5 63.6 (61.8, 68.1) (59.5, 70.0) 69.8 69.6 (65.4, 75.2) (58.2, 82.7) 713 722 (669, 734) (592, 828) 10.5 10.0 (9.0, 11.0) (8.0, 12.0) 6 (5, 7) 7 (4, 9) 4 (3, 5) 3 (1, 5) 4 (3, 4) 3 (2, 5)
0.061
0.512*
0.757
0.101 0.493 0.633 3
0.578 0.032 0.971
P1
P2
0.141
0.586
0.691
0.079
0.166
0.735
0.071* 0.778* 0.072* 0.719* 0.030* 0.478* 0.259* 0.991* 0.564* 0.701* 0.536* 0.509* 0.177 0.632 0.344
0.336 0.932 0.858
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
Skipping breakfast 45 33 40 0.628 0.873 29 30 40 0.127 0.271 †(“yes” answer; %) †Consumption at least 3 meals/day 43 45 36 0.473 0.430 49 63 32 0.058 0.006 (“yes” answer; %) 19.0 19.0 18.5 19.0 19.0 Last meal 20.0 0.171 0.395 0.005 0.380 (19.0, 19.0) (18.5, 19.5) (18.0, 19.0) (19.0, 19.5) (19.0, 20.0) (19.0, 20.0) (time in hours) †Night eating 8 10 11 0.497 0.848 10 12 14 0.246 0.834 (“yes” answer; %) 2.29 2.21 2.14 2.14 2.29 2.0 Screen time 0.027 0.228 0.059 0.097 (2.14, 2.43) (2.0, 2.57) (2.0, 2.29) (2.0, 2.43) (2.14, 2.43) (1.71, 2.29) (hours per day) 8.0 8.0 8.0 8.0 8.0 8.0 Sleep duration 0.541 0.658 0.002 0.021 (8.0, 8.0) (8.0, 8.0) (7.5, 8.0) (8.0, 8.0) (8.0, 8.5) (7.0, 8.0) (hours) 22.0 22.0 22.0 22.0 22.0 22.0 Bedtime 0.616 0.882 0.005 0.616 (22.0, 22.0) (22.0, 22.0) (22.0, 22.5) (22.0, 22.0) (22.0, 22.0) (22.0, 22.5) (at hours) †Snoring 26 9 37 0.255 0.024 43 29 50 0.232 0.114 (“yes” answer; %) Abbreviations: EI, Eating Inventory; MHO, metabolically healthy obesity; MJ, megajoules; MUO, metabolically unhealthy obesity; n, number of subjects †Fisher test was used, data are presented in percentage. Otherwise Mann-Whitney analysis was used. Data are presented as medians (95 % confidence intervals); *After adjustment for BMI z-score. P1 = MHO – regardless waist circumference vs. MUO P2 = MHO – without abdominal obesity vs. MUO
4
ACCEPTED MANUSCRIPT
Highlights About half of obese adolescents exhibited metabolically healthy obesity.
•
Gamma-glutamyl transferase and lipid levels distinguished metabolic phenotypes.
•
Diet composition in obese girls was related to cardiometabolic health status.
•
Hours of sleep and time of last meal in obese boys influenced metabolic health.
•
The prevalence of MHO in adolescents with normal waist circumference was ~8.5 %.
•
Gamma-glutamyl transferase was related to metabolic health status in both genders.
•
Uric acid was associated with abdominal obesity in both genders.
•
Longer sleep and regular meal consumption was associated with MHO in boys.
•
Surprisingly, fat intake was higher in girls with MHO than in those with MUO.
AC C
EP
TE D
M AN U
SC
RI PT
•